Is Guardant Health, Inc. (GH) a Buy, Sell, or Hold?
NASDAQ : GH
Guardant Health, Inc. — Analyst Ratings
$152.14 USD
$4.07 (2.75%)
- Volume
- 741.3K
- Average Volume
- 2.67M
- Market Capitalization
- $20.17B
- P/E Ratio
- -44.88
- Dividend Yield
- 0.00%
- Price Target
- $175.00
- Year High
- $174.08
- Year Low
- $40.35
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.68
Analyst Consensus Summary
Consensus Rating
Sell
30 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-13.1%
vs Current Price
Price Target
$175.00
Average TargetPrice Target Range
Lowest Target
$115.00
32.3% UPSIDE
Average Target
$175.00
Median Estimate
Highest Target
$205.00
-25.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 30
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 29 | 0 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | Kyle Mikson | $205 | $158.4 | 2026-07-14 06:50 AM | 29.4% |
| Evercore ISI | Vijay Kumar | $200 | $169.45 | 2026-07-06 08:43 AM | 18.0% |
| Bernstein | Eve Burstein | $200 | $170.77 | 2026-07-02 07:20 AM | 17.1% |
| RBC Capital | Dan Leonard | $185 | $130.9 | 2026-06-11 04:09 PM | 41.3% |